Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures - PubMed (original) (raw)
. 2006 Sep 22;281(38):27846-54.
doi: 10.1074/jbc.M603721200. Epub 2006 Jul 24.
Affiliations
- PMID: 16867995
- DOI: 10.1074/jbc.M603721200
Free article
Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures
Mark C Wilkes et al. J Biol Chem. 2006.
Free article
Abstract
Transforming growth factor beta (TGF-beta) modulates a number of cellular phenotypes as divergent as growth stimulation and growth inhibition. Although the Smad pathway is critical for many of these responses, recent evidence indicates that Smad-independent pathways may also have a critical role. One such protein previously shown to regulate TGF-beta action independent of the Smad proteins is the c-Abl nonreceptor tyrosine kinase. In the current study we determined that TGF-beta receptor signaling activates c-Abl kinase activity in a subset of fibroblast but not epithelial cultures. This cell type-specific response occurs in a membrane-proximal locale independent of receptor internalization and upstream of dynamin action. Although c-Abl activation by TGF-beta is independent of Smad2 or Smad3, it is prevented by inhibitors of phosphatidylinositol 3-kinase or PAK2. Thus, c-Abl represents a target downstream of phosphatidylinositol 3-kinase-activated PAK2, which differentiates TGF-beta signaling in fibroblasts and epithelial cell lines and integrates serine/threonine receptor kinases with tyrosine kinase pathways.
Similar articles
- Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
Wang S, Wilkes MC, Leof EB, Hirschberg R. Wang S, et al. FASEB J. 2005 Jan;19(1):1-11. doi: 10.1096/fj.04-2370com. FASEB J. 2005. PMID: 15629889 - Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.
Wilkes MC, Murphy SJ, Garamszegi N, Leof EB. Wilkes MC, et al. Mol Cell Biol. 2003 Dec;23(23):8878-89. doi: 10.1128/MCB.23.23.8878-8889.2003. Mol Cell Biol. 2003. PMID: 14612425 Free PMC article. - [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R. Yuki R. Yakugaku Zasshi. 2021;141(11):1229-1234. doi: 10.1248/yakushi.21-00143. Yakugaku Zasshi. 2021. PMID: 34719542 Review. Japanese. - Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N. Kamato D, et al. Cell Signal. 2013 Oct;25(10):2017-24. doi: 10.1016/j.cellsig.2013.06.001. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770288 Review.
Cited by
- c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts.
Karimizadeh E, Gharibdoost F, Motamed N, Jafarinejad-Farsangi S, Jamshidi A, Mahmoudi M. Karimizadeh E, et al. Mol Cell Biochem. 2015 Jul;405(1-2):169-76. doi: 10.1007/s11010-015-2408-0. Epub 2015 Apr 16. Mol Cell Biochem. 2015. PMID: 25876876 - A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.
Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, Hinchcliff M, Leof E, Varga J. Bhattacharyya S, et al. Oncogene. 2009 Mar 12;28(10):1285-97. doi: 10.1038/onc.2008.479. Epub 2009 Jan 19. Oncogene. 2009. PMID: 19151753 Free PMC article. - Integrative modeling and analysis of signaling crosstalk reveal molecular switches coordinating Yes-associated protein transcriptional activities.
Ghomlaghi M, Theocharous M, Hoang N, Shin SY, von Kriegsheim A, O' Neill E, Zhang T, Nguyen LK. Ghomlaghi M, et al. iScience. 2024 Jan 26;27(3):109031. doi: 10.1016/j.isci.2024.109031. eCollection 2024 Mar 15. iScience. 2024. PMID: 38380257 Free PMC article. - The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM, Schiemann WP. Allington TM, et al. Cells Tissues Organs. 2011;193(1-2):98-113. doi: 10.1159/000320163. Epub 2010 Nov 3. Cells Tissues Organs. 2011. PMID: 21051857 Free PMC article. Review. - ERBB receptor activation is required for profibrotic responses to transforming growth factor beta.
Andrianifahanana M, Wilkes MC, Repellin CE, Edens M, Kottom TJ, Rahimi RA, Leof EB. Andrianifahanana M, et al. Cancer Res. 2010 Oct 1;70(19):7421-30. doi: 10.1158/0008-5472.CAN-10-0232. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous